{"schema_version":"secwatch.filing_event.v1","accession":"0001438133-23-000008","form_type":"8-K","ticker":"TNDM","cik":"0001438133","company_name":"TANDEM DIABETES CARE INC","filed_at":"2023-01-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.998098+00:00","generated_at":"2026-06-20T11:40:54.434296+00:00","sec_items":["2.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Tandem Diabetes completes acquisition of AMF Medical for CHF 70.4M upfront plus earnouts","bullets":["Total upfront consideration: CHF 8.0M strategic investment (Q3 2022) plus CHF 62.4M cash at closing.","Acquisition closed on January 19, 2023; additional contingent earnout payments may follow.","Target: AMF Medical SA, a Swiss diabetes technology company; adds to Tandem's product portfolio.","Transaction previously disclosed in December 2022; Purchase Agreement filed with 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001438133-23-000008","json":"https://secwatch.observer/filing/0001438133-23-000008.json","markdown":"https://secwatch.observer/filing/0001438133-23-000008.md","text":"https://secwatch.observer/filing/0001438133-23-000008.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1438133/000143813323000008/0001438133-23-000008-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1438133/000143813323000008/tndm-20230119.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T11:40:54.434296+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0a1e4c44d65210c87f42aeae3d5dc67675e6b454","claim":"TANDEM DIABETES CARE INC completed an acquisition involving AMF Medical SA for a previous strategic investment of Swiss Francs (\"CHF\") 8.0 million paid in the third quarter of 2022, a cash payment of CHF 62.4 million paid at the closing of (closed 2023-01-19).","evidence_excerpt":"e Company entered into a Share Purchase Agreement, dated as of December 10, 2022 (the “Purchase Agreement”), by and among the Company, the Sellers listed on Annex B of the Purchase Agreement (collectively, the “Sellers” and each, individually, a “Seller”) and AMF Medical SA, a corporation organized and existing under the laws of Switzerland (“AMF Medical”).","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813323000008/0001438133-23-000008-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"AMF Medical SA"},{"label":"Consideration","value":"a previous strategic investment of Swiss Francs (\"CHF\") 8.0 million paid in the third quarter of 2022, a cash payment of CHF 62.4 million paid at the closing of"},{"label":"Closing","value":"2023-01-19"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}